Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6091 to 6105 of 7706 results

  1. Workplace:- How effective are interventions in the workplace that aim to prevent infection and reduce antimicrobial resistance?

    Recommendation ID NG63/4 Question Workplace:- How effective are interventions in the workplace that aim to prevent infection and reduce

  2. How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Recommendation ID PH43/10 Question How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population

  3. How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Recommendation ID PH43/9 Question How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population

  4. Impact of drug-related adverse effects on cost effectiveness and quality of life:- What is the impact of drug-related adverse effects on health economics and quality of life in neuropathic pain?

    Recommendation ID CG173/5 Question Impact of drug-related adverse effects on cost effectiveness and quality of life:- What is the impact

  5. Individual versus group CBT for children and young people with social anxiety disorder:- What is the clinical and cost effectiveness of individual and group CBT for children and young people with social anxiety disorder?

    Recommendation ID CG159/4 Question Individual versus group CBT for children and young people with social anxiety disorder:- What is the

  6. In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal urinary antigen testing in addition to other routine tests improve outcomes?

    Recommendation ID CG191/1 Question In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal urinary

  7. In patients with muscle-invasive bladder cancer suitable for radical treatment, does the use of biomarkers enable patients to select more effective treatment, and improve their outcomes, compared with treatment selected without biomarkers?

    Recommendation ID NG2/4 Question In patients with muscle-invasive bladder cancer suitable for radical treatment, does the use of biomarkers

  8. Inhibitors of functional ability:- What are the greatest inhibitors of functional ability in children and young people with upper motor neurone lesions?

    Recommendation ID CG145/1 Question Inhibitors of functional ability:- What are the greatest inhibitors of functional ability in children

  9. Frequency of follow-up imaging:- What is the clinical and cost effectiveness of 6-monthly imaging for 3 years for people with recurrent calcium renal or ureteric stones?

    Recommendation ID NG118/4 Question Frequency of follow-up imaging:- What is the clinical and cost effectiveness of 6-monthly imaging for

  10. Premature ovarian insufficiency:- What are the main clinical manifestations of premature ovarian insufficiency and the short- and long-term impact of the most common therapeutic interventions?

    Recommendation ID NG23/5 Question Premature ovarian insufficiency:- What are the main clinical manifestations of premature ovarian insufficiency

  11. Effects of HRT on breast cancer risk:- What is the difference in the risk of breast cancer in menopausal women on HRT with progesterone, progestogen or selective oestrogen receptor modulators?

    Recommendation ID NG23/2 Question Effects of HRT on breast cancer risk:- What is the difference in the risk of breast cancer in menopausal

  12. Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous thromboembolism (VTE)?

    Recommendation ID NG23/3 Question Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous

  13. Women with breast cancer:- What is the safety and effectiveness of alternatives to systemic HRT as treatments for menopausal symptoms in women who have had treatment for breast cancer?

    Recommendation ID NG23/1 Question Women with breast cancer:- What is the safety and effectiveness of alternatives to systemic HRT as treatments